
For decades, beauty product innovation relied on a narrow set of familiar ingredients discovered largely by chance and repurposed through reformulation, with innovative textures adding consumer appeal. The industry mined nature for what evolution provided, drawing on known ingredient libraries and the same iterative testing. Brands relied on one-size-fits-all ingredients. Development cycles stretched on for years–slow, resource-intensive, predictable and inherently limited.
Joshua Britton, Ph.D.Debut
With this playbook, we can take over where innovation left off, accelerating millions of years of evolution to design targeted ingredients at incredible speed that deliver clinically validated performance in emerging areas of skin science. The universe of possibilities is no longer bound by what can be cultivated or grown in forests. Beauty has barely scratched the surface of ingredient possibilities with biology only now becoming accessible at scale. The molecules that brands rely on account for only 0.001% of what is possible. The new playbook taps into the remaining 99.999%. The claims driving beauty 10 years from now will be completely different–people will laugh at today’s traditional methods!
Designing Beauty from the Pathway Up
This shift doesn’t only accelerate discovery. It changes the very definition of what an ingredient can be. Instead of hoping a naturally occurring molecule, or one derived from traditional chemistry, might influence a desired pathway, scientists can now begin with the pathway itself and work backward, creating a molecule tailored to that specific biological mechanism and powering a new generation of science-backed claims. It’s a reversal of the logic of traditional beauty R&D, replacing serendipity with advanced molecular research and expanding performance far beyond the limits of extraction. In the era of biotechnology, ingredient suppliers aren’t just rethinking how they sell beauty actives, they must overhaul their entire five-year pipeline. It’s a total 180 in workflows.
AI can design and computationally analyze billions of molecules and identify which ones will activate specific biological pathways tied to skin longevity. This allows scientists to design ingredients that optimize performance and deliver first-of-their-kind product benefits. Examples include professional-level skin tightening in topical form and potent yet safe alternatives to kojic acid and retinol which are increasingly being regulated due to health concerns at high concentrations. Imagine what can be achieved when you take a science-up approach to product development instead of a plant extract-down approach.
Advanced genomic tools let scientists predict how ingredients interact with skin at the cellular level–activating pathways, influencing gene expression, and supporting long-term skin health – creating a pipeline of high-performance ingredients ready before they reach the formulation lab.
The Genentech Moment for Beauty: Science Takes the Lead
The new way of beauty R&D is faster, smarter, and more precise than ever, enabling brands to create groundbreaking products that address emerging skin health needs and deliver meaningful results to consumers. The platform ensures targeted solutions without compromising safety. Powered by biology, it delivers sustainable ingredients with best-in-class efficacy, combined with formulation textures that enhance the overall consumer experience.
Beauty is entering the same transformation pharmaceuticals did in 1976 when biotech company Genentech was born, from discovery by chance to discovery by design. Brands that embrace this new frontier unlock unparalleled innovation and a clear and lasting competitive edge. The most successful brands of the next decade won’t merely reformulate legacy actives. They’ll redefine what high-performance means in beauty.










